Fintel reports that on January 31, 2025, Evercore ISI Group initiated coverage of NNN REIT (NYSE:NNN) with a In-Line ...
Evercore ISI analyst John Dunn maintained a Hold rating on Janus Henderson Group (JHG – Research Report) today. The company’s shares closed ...
Evercore ISI analyst Glenn Schorr maintained a Buy rating on Blackstone Group (BX – Research Report) on January 31 and set a price target of ...
Fintel reports that on January 28, 2025, Evercore ISI Group initiated coverage of Mind Medicine (NasdaqGS:MNMD) with a ...
Fintel reports that on January 31, 2025, Evercore ISI Group initiated coverage of NNN ... See our leaderboard of companies with the largest price target upside. The projected annual revenue ...
Fintel reports that on January 21, 2025, Evercore ISI Group upgraded their outlook for ... 11,344K shares representing 5.60% ownership of the company. In its prior filing, the firm reported ...
Akero Therapeutics reports positive mid-stage data for efruxifermin - its candidate treatment for cirrhosis. Akero stock rallied over 100%.